SILVERBERG, J. I.; CORK, M.; WOLLENBERG, A.; KATOH, N.; STEFFENSEN, L. A.; KURBASIC, A.; OLSEN, C. K.; KUZNETSOVA, A.; ?STERDAL, M. L.; VILSB?LL, A. W.; DELEURAN, M. Early Changes in Patient-Relevant Endpoints in Three Tralokinumab Pivotal Phase 3 Trials (ECZTRA 1−3) in Adult Patients with Moderate-to-Severe Atopic Dermatitis. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 4, n. 6, p. s98, 2020. DOI: 10.25251/skin.4.supp.98. Disponível em: https://jofskin.org/index.php/skin/article/view/1068. Acesso em: 3 jul. 2024.